The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.


January 23, 2021

KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE* 4 carriers

Belloy, M. E., Eger, S. J., Le Guen, Y., Napolioni, V., Deters, K. D., Yang, H. S., … & Alzheimer’s Disease Neuroimaging Initiative. Neurobiol Aging. 2021 May; 101: 123–129.

Your upload was successful!